Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001144204-17-017314
Filing Date
2017-03-29
Accepted
2017-03-29 17:00:21
Documents
1
Effectiveness Date
2017-03-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11145
  Complete submission text file 0001144204-17-017314.txt   12268
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: D | Act: 33 | File No.: 021-283590 | Film No.: 17722845
SIC: 2834 Pharmaceutical Preparations